Keros Therapeutics, Inc. revenue breakdown overview

Keros Therapeutics, Inc. revenue for the last year amounted to 151.00 k USD, the most of which — 151.00 k USD — came from its highest performing source at the moment, Therapeutics for Hematological, Pulmonary and Cardiovascular Disorders, the year earlier bringing 20.10 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Keros Therapeutics, Inc. 151.00 k USD, and the year before that — 20.10 M USD.